The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 10,701–10,800 of 31,469
IL-34 causes inflammation and beta cell apoptosis and dysfunction in gestational diabetes mellitus
Piao, C., Wang, X., Peng, S., Guo, X., Zhao, H., Li, H., Zeng, Y., Zhang, F., Zhu, K., & Wang, Y. (2019) · Endocrine Connections · doi:10.1530/ec-19-0436 · Cited by 35
New insight into the mechanisms of ectopic fat deposition improvement after bariatric surgery
Angelini, G., Castagneto‐Gissey, L., Corpo, G. D., Giordano, C., Cerbelli, B., Severino, A., Manco, M., Basso, N., Birkenfeld, A. L., Bornstein, S. R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53702-4 · Cited by 33
Clinical and molecular evidence of accelerated ageing following very preterm birth
Parkinson, J. R. C., Emsley, R., Tarry‐Adkins, J. L., Longford, N., Ozanne, S. E., Holmes, E. C., & Modi, N. (2019) · Pediatric Research · doi:10.1038/s41390-019-0709-9 · Cited by 32
Fuglsang-Nielsen, R., Rakvaag, E., Vestergaard, P., et al. (2020) · Bone · doi:10.1016/j.bone.2020.115230 · Cited by 33
Brand, C., Martins, C., Lemes, V. B., Pessoa, M. L. F., Dias, A. F., Cadore, E. L., Mota, J. A. P. S., Gaya, A. C. A., & Gaya, A. R. (2020) · Journal of Sports Sciences · doi:10.1080/02640414.2020.1725384 · Cited by 37
Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
Schwartz, G. G., Leiter, L. A., Ballantyne, C. M., Barter, P. J., Black, D. M., Kallend, D. G., Laghrissi‐Thode, F., Leitersdorf, E., McMurray, J. J. V., Nicholls, S. J., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2204 · Cited by 34
Association of Serum Homocysteine Levels with Histological Severity of NAFLD
Xu, Y., Guan, Y., Yang, X., Xia, Z., & Wu, J. (2020) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-529 · Cited by 33
Sleep Characteristics and Measures of Glucose Metabolism in Blacks: The Jackson Heart Study
Yano, Y., Gao, Y. L., Johnson, D. A., Carnethon, M. R., Correa, A., Mittleman, M. A., Sims, M., Mostofsky, E., Wilson, J. G., & Redline, S. S. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013209 · Cited by 33
Chao, Y., Wu, K. L. H., Tsai, P.-C., Tain, Y., Leu, S., Lee, W., & Chan, J. Y. H. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00660-z · Cited by 35
Insulin Resistance Predicts Severity of Coronary Atherosclerotic Disease in Non-Diabetic Patients
Strisciuglio, T., Izzo, R., Barbato, E., Gioia, G. D., Colaiori, I., Fiordelisi, A., Morisco, C., Bartúnek, J., Franco, D., Ammirati, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072144 · Cited by 33
Zong, J., Sun, Y., Zhang, Y., Yuan, J., Wang, X., Zhang, R., Zhao, X., Zhao, X., & Gu, Y. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s260891 · Cited by 33
Chaplin, A. M. L., Gao, H., Asase, C., Palanivel, R., Park, B., Skander, D., Bebek, G., Rajagopalan, S., & Maiseyeu, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-69745-x · Cited by 34
Small intestinal metabolism is central to whole-body insulin resistance
Angelini, G., Salinari, S., Castagneto‐Gissey, L., BERTUZZI, A., Casella-Mariolo, J. R., Ahlin, S., Boškoski, I., Gaggini, M., Raffaelli, M., Costamagna, G., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322073 · Cited by 33
Li, L., Spranger, L., Soll, D., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154401 · Cited by 33
Amat-Bou, M., Garcia-Ribera, S., Climent, E., Piquer‐Garcia, I., Corripio, R., Sánchez-Infantes, D., Villalta, L., Elías, M., Jiménez‐Chillarón, J. C., Chenoll, E., et al. (2020) · Nutrients · doi:10.3390/nu12103123 · Cited by 33
PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
Lisboa, Q. C., Nardelli, M. J., Pereira, P. D. A., de Miranda, D. M., Ribeiro, S. N., da Costa, R. S. N., Versiani, C. A., Vidigal, P. V. T., Ferrari, T. C. A., & Couto, C. A. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i10.792 · Cited by 36
Cheong, J. L. Y., Haikerwal, A., Wark, J. D., Irving, L. B., Garland, S. M., Patton, G. C., Cheung, M. M. H., Doyle, L. W., & for the Victorian Infant Collaborative Study Group (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15786 · Cited by 34
Jujić, A., Nilsson, P. M., Atabaki‐Pasdar, N., Dieden, A., Tuomi, T., Franks, P. W., Holst, J. J., Torekov, S. S., Ravassa, S., Dı́ez, J., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1318 · Cited by 33
Longitudinal plasma protein profiling of newly diagnosed type 2 diabetes
Gummesson, A., Björnson, E., Fagerberg, L., Zhong, W., Tebani, A., Edfors, F., Schmidt, C., Lundqvist, A., Adiels, M., Bäckhed, F., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103147 · Cited by 34
McCann, J. R., Bihlmeyer, N. A., Roche, K. E., Catherine, C., Jawahar, J., Kwee, L. C., Younge, N. E., Silverman, J. D., Ilkayeva, O., Sarria, C., et al. (2021) · Obesity · doi:10.1002/oby.23081 · Cited by 31
McKenna, C. F., Salvador, A. F., Hughes, R., Scaroni, S. E., Alamilla, R. A., Askow, A. T., Paluska, S. A., Dilger, A. C., Holscher, H. D., Lisio, M. D., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00574.2020 · Cited by 38
Gordon, P., Farkas, G. J., & Gater, D. R. (2021) · Topics in Spinal Cord Injury Rehabilitation · doi:10.46292/sci20-00063 · Cited by 34
Gao, Y., Tsintzas, K., Macdonald, I. A., Cordon, S. M., & Taylor, M. A. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00909-2 · Cited by 43
Associations between ghrelin and leptin and neural food cue reactivity in a fasted and sated state
Wever, M. C. M., van Meer, F., Charbonnier, L., Crabtree, D. R., Buosi, W., Giannopoulou, A., Androutsos, O., Johnstone, A. M., Μanios, Y., Meek, C. L., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118374 · Cited by 34
Miao, G., Zhang, Y., Huo, Z., Zeng, W., Zhu, J., Umans, J. G., Wohlgemuth, G., Pedrosa, D., DeFelice, B. C., Cole, S. A., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0451 · Cited by 33
Effect of LncPVT1/miR-20a-5p on Lipid Metabolism and Insulin Resistance in NAFLD
Zhang, H., Niu, Q., Liang, K., Li, X., Jiang, J., & Bian, C. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s338097 · Cited by 33
Association of thyroid function with insulin resistance: data from two population-based studies
Spira, D., Buchmann, N., Dörr, M., Markus, M. R. P., Nauck, M., Schipf, S., Spranger, J., Demuth, I., Steinhagen-Thiessen, E., Völzke, H., et al. (2022) · European Thyroid Journal · doi:10.1530/etj-21-0063 · Cited by 34
Overberg, J., Kalveram, L., Keller, T., Krude, H., Kühnen, P., & Wiegand, S. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01077-4 · Cited by 35
Chen, G., Chai, J. C., Xing, J., Moon, J., Shan, Z., Yu, B., Mossavar‐Rahmani, Y., Sotres‐Alvarez, D., Li, J., Mattei, J., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05690-w · Cited by 39
Artichoke Leaf Extract‐Mediated Neuroprotection against Effects of Aflatoxin in Male Rats
Ibrahim, E. A., Yousef, M. I., Ghareeb, D. A., Augustyniak, M., Giesy, J. P., Aboul‐Soud, M. A. M., & Wakil, A. E. (2022) · BioMed Research International · doi:10.1155/2022/4421828 · Cited by 33
Kang, N., Wu, R., Liao, W., Zhang, C., Liu, X., Mao, Z., Huo, W., Hou, J., Zhang, K., Tian, H., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.160364 · Cited by 33
Yanagimoto, A., Matsui, Y., Yamaguchi, T. F., Hibi, M., Kobayashi, S., & Osaki, N. (2022) · Nutrients · doi:10.3390/nu14235063 · Cited by 42
Statins do not decrease small, dense low-density lipoprotein.
Choi, C. U., Seo, H. S., Lee, E. M., Shin, S. Y., Choi, U.-J., Na, J. O., Lim, H. E., Kim, J. W., Kim, E. J., Rha, S., et al. (2010) · PubMed Central · Cited by 33
Tovar, J., Johansson, M., & Björck, I. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-1039-2 · Cited by 33
Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats
Jia, D. M., Fukumitsu, K.-I., Tabaru, A., Akiyama, T., & Otsuki, M. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.5.r1332 · Cited by 33
Effects of Lonicera japonica Thunb. on Type 2 Diabetes via PPAR-γ Activation in Rats
Han, J. M., Kim, M. H., Choi, Y. Y., Lee, H., Hong, J., & Yang, W. M. (2015) · Phytotherapy Research · doi:10.1002/ptr.5413 · Cited by 35
Tabaton, M., Odetti, P. R., Cammarata, S., Borghi, R., Monacelli, F., Caltagirone, C., Bossù, P., Buscema, M., & Grossi, E. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1300 · Cited by 33
Hu, C., Jia, W., Zhang, R., Wang, C., Lu, J., Wu, H., Fang, Q., Ma, X., & Xiang, K. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02314.x · Cited by 34
Komiya, H., Mori, Y., YOKOSE, T., Kurokawa, N., Horie, N., & Tajima, N. (2006) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13.136 · Cited by 34
Tanaka, S., Wu, B., Honda, M., Suzuki, K., Yoshino, G., Fukuo, K., & Kazumi, T. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7229 · Cited by 33
Lumiaho, A., Pihlajamäki, J., Hartikainen, J. E. K., Ikäheimo, R., Miettinen, R., Niemitukia, L. H., Lampainen, E., & Laakso, M. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00354-8 · Cited by 33
Dullaart, R. P. F., Groen, A. K., Dallinga‐Thie, G. M., de Vries, R., Sluiter, W. J., & van Tol, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0451 · Cited by 34
Profka, E., Giavoli, C., Bergamaschi, S., Ferrante, E., Malchiodi, E., Sala, E., Verrua, E., Rodari, G., Filopanti, M., Beck‐Peccoz, P., et al. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0196-0 · Cited by 35
Seet, R. C. S., Zhang, Y., Wijdicks, E. F. M., & Rabinstein, A. A. (2012) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2012.04.001 · Cited by 33
Clinical and Metabolic Features of Polycystic Ovary Syndrome among Chinese Adolescents
Li, L., Chen, X., He, Z., Zhao, X., Huang, L., & Yang, D. (2012) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2012.07.006 · Cited by 33
Chistiakov, D. A., Potapov, V. A., Khodirev, D. S., Шамхалова, М. Ш., Shestakova, M. V., & Nosikov, V. V. (2009) · Diabetes and Vascular Disease Research · doi:10.1177/1479164109347689 · Cited by 33
Verit, F. F. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1226-6 · Cited by 33
Metwalley, K. A., Farghaly, H. S., & Hafeez, H. A. A. E. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.117234 · Cited by 33
Hypertension and the Risk of Breast Cancer in Chilean Women: a Case-control Study
Pereira, A. P. R., Garmendia, M. L., Alvarado, M. E., & Cecilia Albala, B. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.11.5829 · Cited by 33
Nakashima, R., Yamane, K., Kamei, N., Nakanishi, S., & Kohno, N. (2011) · PubMed · doi:10.3275/7409 · Cited by 32
Insulin resistance in migraineurs: Results from a case-control study
Sacco, S., Altobelli, E., Ornello, R., Ripa, P., Pistoia, F., & Carolei, A. (2013) · Cephalalgia · doi:10.1177/0333102413511155 · Cited by 34
Relationship of adiponectin to serum paraoxonase 1
Bajnok, L., Csongrádi, É., Seres, I., Varga, Z., Jeges, S., Peti, A., Karányi, Z., Juhász, A., Mezősi, E., Nagy, E. V., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.06.001 · Cited by 33
Şit, D., Kadiroğlu, A. K., Yılmaz, M. E., et al. (2005) · Renal Failure · doi:10.1081/jdi-200065318 · Cited by 33
Oba, S., Suzuki, E., Yamamoto, M., Horikawa, Y., Nagata, C., & Takeda, J. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.09.002 · Cited by 33
Shin, M., Kanaya, A. M., & Krauss, R. M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.10.004 · Cited by 33
Cocate, P. G., de Oliveira, A., Hermsdorff, H. H. M., Alfenas, R. D. C. G., Amorim, P. R. D. S., Longo, G. Z., Pelúzio, M. D. C. G., de Faria, F. R., & Natali, A. J. (2013) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2013.04.017 · Cited by 33
Aschbacher, K., Adam, E. K., Crofford, L. J., Kemeny, M. E., Demitrack, M. A., & Ben-Zvi, A. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.002 · Cited by 33
Atabek, M. E., Pirgon, Ö., & Kurtoğlu, S. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00601.x · Cited by 34
Farrokhfall, K., Khoshbaten, A., Zahediasl, S., Mehrani, H. A., & Karbalaei, N. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2014.07.014 · Cited by 34
Kawamoto, R., Kohara, K., Tabara, Y., Miki, T., Ohtsuka, N., Kusunoki, T., & Abe, M. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.218.331 · Cited by 33
Impact of the metabolic syndrome on subcutaneous microcirculation in obese patients
Grassi, G. M., Seravalle, G., Brambilla, G., Facchetti, R., Bolla, G. B., Mozzi, E., & Mancia, G. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833af3c9 · Cited by 33
Relationship between Homocysteine and Insulin Resistance in Women with Polycystic Ovary Syndrome
Okman, T. K., Güldiken, S., & Küçük, M. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.505 · Cited by 33
González, F., Minium, J., Rote, N. S., & Kirwan, J. P. (2006) · Metabolism · doi:10.1016/j.metabol.2005.08.022 · Cited by 33
Cordido, F., García‐Buela, J., Sangiao‐Alvarellos, S., Martínez, T., & Vidal, O. (2010) · Mediators of Inflammation · doi:10.1155/2010/434562 · Cited by 33
Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?
Montesi, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.10128 · Cited by 34
Lin, C., Liu, C.-S., Li, C.-I., Lin, C., Lai, M.-M., Lin, T., Chang, P.-C., Lee, Y.-D., Chen, C., Lin, C., et al. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-484 · Cited by 33
Serum adiponectin in chronic hepatitis C and B
Siagris, D., Vafiadis, G., Michalaki, M. A., Lekkou, A., Starakis, I., Makri, M. G., Margaritis, V., Christofidou, M., Tsamandas, A. C., & Labropoulou‐Karatza, C. (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2007.00850.x · Cited by 33
Özkaya, M., Şahi̇n, M., Çakal, E., Yüzbaşıoğlu, M. F., Sezer, K., Kilinc, M., & Imrek, S. S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346482 · Cited by 33
ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes in North Indians
Bhatti, J. S., Bhatti, G. K., Mastana, S. S., et al. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0579-2 · Cited by 33
Docosahexaenoic Acid Content in Plasma Phospholipids and Desaturase Indices in Obese Children
Saito, E., Okada, T., Abe, Y., Kuromori, Y., Miyashita, M., Iwata, F., Hara, M., Ayusawa, M., Mugishima, H., & Kitamura, Y. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.6270 · Cited by 33
Type of vegetable oils used in cooking and risk of metabolic syndrome among Asian Indians
Lakshmipriya, N., Gayathri, R., Praseena, K., Vijayalakshmi, P., Geetha, G., Sudha, V., Krishnaswamy, K., Anjana, R. M., Henry, C. J., & Mohan, V. (2012) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2012.728197 · Cited by 33
Koga, M., Hirata, T., Kasayama, S., Ishizaka, Y., & Yamakado, M. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.07.035 · Cited by 35
Nonalcoholic Fatty Liver Disease Markers Are Associated with Insulin Resistance in Type 1 Diabetes
Bulum, T., Kolarić, B., Duvnjak, L. S., & Duvnjak, M. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1807-7 · Cited by 33
Reddigan, J. I., Riddell, M. C., & Kuk, J. L. (2011) · Diabetologia · doi:10.1007/s00125-011-2374-3 · Cited by 31
Sert, A., Pirgon, Ö., Aypar, E., Yılmaz, H. S., & Odabaş, D. (2013) · Pediatric Cardiology · doi:10.1007/s00246-013-0638-z · Cited by 33
Babu, A., Mehta, A., Guerrero, P., Chen, Z., Meyer, P. M., Koh, C. K., Roberts, R., Schaider, J., & Fogelfeld, L. (2009) · Endocrine Practice · doi:10.4158/ep09117.orr · Cited by 34
Bellisle, F., Dalix, A. M., de Assis, M. A. A., Kupek, E. J., Gerwig, U., Slama, G., & Oppert, J. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507450309 · Cited by 33
Aging Linked to Type 2 Diabetes Increases Oxidative Stress and Chronic Inflammation
Mendoza-Núñez, V. M., Rosado-Pérez, J., Santiago‐Osorio, E., Ortiz, R., Sánchez-Rodrı́guez, M. A., & Galván-Duarte, R. E. (2011) · Rejuvenation Research · doi:10.1089/rej.2010.1054 · Cited by 34
Al-Isa, A. N., Thalib, L., & Akanji, A. O. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.07.056 · Cited by 33
Mathijs, I., Cunha, D. A., Himpe, E., Ladrière, L., Chellan, N., Roux, C. R., Joubert, E., Muller, C. J. F., Cnop, M., Louw, J., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400211 · Cited by 33
Effect of CLA isomers and their mixture on aging C57Bl/6J mice
Halade, G. V., Rahman, M. M., & Fernandes, G. (2009) · European Journal of Nutrition · doi:10.1007/s00394-009-0029-7 · Cited by 33
Káposztás, Z., Gyürüs, É., & Kahan, B. D. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.04.008 · Cited by 33
Hitze, B., Bosy‐Westphal, A., Bielfeldt, F., Settler, U., Mönig, H., & Müller, M. J. (2008) · Obesity Facts · doi:10.1159/000157248 · Cited by 34
Study on Chronic Low-Grade Inflammation and Influential Factors of Polycystic Ovary Syndrome
Ruan, X., & Dai, Y. (2009) · Medical Principles and Practice · doi:10.1159/000189809 · Cited by 34
Cenci, M. C. P., Conceição, F. L., Soares, D. V., Spina, L. D. C., Brasil, R. R. L. O., Lobo, P. M., Micmacher, E., & Vaisman, M. (2007) · Metabolism · doi:10.1016/j.metabol.2007.08.015 · Cited by 33
Hwang, Y., Jung, C. H., Ahn, H. Y., Jeon, W. S., Jin, S., Woo, J., Soo, B., Kim, J. H., Park, C., & Lee, B. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.06.027 · Cited by 33
Women with severe obesity and relatively low bone mineral density have increased fracture risk
Cawsey, S., Padwal, R. S., Sharma, A. M., Wang, X., Li, S., & Siminoski, K. G. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2833-z · Cited by 33
Bergholm, R., Sevastianova, K., Santos, A., Kotronen, A., Urjansson, M., Hakkarainen, A., Lundbom, J., Tiikkainen, M., Rissanen, A., Lundbom, N. M. I., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.116 · Cited by 33
Afşar, B., Sezer, S., Elsürer, R., & Özdemir, F. N. (2007) · Blood Pressure Monitoring · doi:10.1097/mbp.0b013e3280b08379 · Cited by 32
Asselin, C., Ducharme, A., Ntimbane, T., Ruiz, M., Fortier, A., Guertin, M., Lavoie, J., Díaz, A., Levy, E. H., Tardif, J., et al. (2013) · Redox Biology · doi:10.1016/j.redox.2013.12.009 · Cited by 33
Lucero, D., Zago, V., Lopez, G. I., Graffigna, M. N., López, G. H., Fainboim, H. A., Miksztowicz, V., Rosso, L. A. G., Belli, S., Levalle, O. A., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.12.012 · Cited by 33
Jun, D. W., Han, J. H., Jang, E. C., et al. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283196adc · Cited by 33
Effect of Propolis on Insulin Resistance in Fructose-drinking Rats
Zamami, Y., Takatori, S., Koyama, T., Goda, M., Iwatani, Y., Doi, S., & Kawasaki, H. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.2065 · Cited by 33
Bao, Y., Zhou, J., Zhou, M., Cheng, Y., Lu, W., Pan, X., Tang, J., Lu, H., & Jia, W. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05361.x · Cited by 33
Rendo‐Urteaga, T., García-Calzón, S., González‐Muniesa, P., Milagro, F. I., Chueca, M., Oyarzabal, M., Azcona, C., Martínez, J. A., & Martí, A. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514003584 · Cited by 34
Barbosa, K. B., Volp, A. C. P., Hermsdorff, H. H. M., et al. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-61 · Cited by 33
Pegvisomant increases intra-abdominal fat in patients with acromegaly: a pilot study.
Plöckinger, U., & Reuter, T. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0637 · Cited by 33
Vitamin D status in diabetic Egyptian children and adolescents: a case–control study
Azab, S. F. A., Saleh, S. H. A., Elsaeed, W. F., et al. (2013) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/1824-7288-39-73 · Cited by 33
Palmer, C. S., Corpuz, T. M., Guirguis, M., O'Toole, S. A., Yan, K. K.-L., Bu, Y., Jorgenson, J., Talbot, M. L., Loi, K., Lloyd, A. R., et al. (2009) · Gut · doi:10.1136/gut.2008.165316 · Cited by 33
Sørensen, L. P., Parkner, T., Søndergaard, E., et al. (2015) · Endocrine Connections · doi:10.1530/ec-14-0107 · Cited by 33
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
